The entropic brain - revisited
This theory-building article (2017) offers more evidence for the entropic brain hypothesis, a hypothesis that under psychedelics the brain reaches higher criticality and is more susceptible to set and setting (bottom-up information). The study serves as a (possible) framework for why psychedelics work so well for a variety of mental disorders (in combination with psychotherapy).
Abstract
It is shown that the principle that the entropy of brain activity is elevated in the psychedelic state is increasingly well supported by separate and independent studies and analyses, and evidence for greater brain criticality under psychedelics is also highlighted. It is argued that heightened brain criticality enables the brain to be more sensitive to intrinsic and extrinsic perturbations which may translate as a heightened susceptibility to “set” and “setting”. This updated version of the original entropic brain hypothesis now offers more concrete information on specific measures of brain entropy and suggests new studies to scrutinise it further, as well as examine its utility for describing and informing the treatment of psychiatric and neurological conditions such as depression and disorders of consciousness.”
Research Summary of 'The entropic brain - revisited'
βBlossom's Take
Introduction
Carhart-Harris revisits the 'entropic brain' hypothesis, which proposes that the information-theoretic entropy of spontaneous brain activity indexes the richness or informational content of conscious states. The original idea linked higher entropy in neural signals to richer, more variable conscious experience and drew much of its motivation from studies of classic serotonergic psychedelics, which were reported to elevate measures of brain entropy. This update aims to integrate empirical findings published since the 2014 paper, make more explicit claims about which entropy measures are most relevant, relate entropy to the notion of criticality in brain dynamics, and propose concrete empirical and clinical applications. Key aims include specifying usable measures of brain entropy, suggesting ways to test the theory (for example, in studies of emotional insight and disorders of consciousness), and linking recent serotonin research to the entropic-brain framework.
Methods
The paper is a narrative review and theoretical update rather than a formal systematic review or meta-analysis. The extracted text reports that the author conducted a literature survey (a PubMed search at submission in January 2018) and synthesised empirical neuroimaging work published since the original 2014 paper; no formal eligibility criteria, data extraction protocol, or risk-of-bias assessment are described in the extracted text. Carhart-Harris integrates findings from EEG, MEG and fMRI studies of psychedelics, reports applications of specific signal-complexity measures (notably Lempel-Ziv complexity), discusses new analytic approaches such as connectome harmonics and perturbational-complexity indices (PCI), and combines these empirical results with theoretical discussion about criticality and serotonin function. The paper also outlines proposed experimental paradigms (for example, experience sampling with music during scanning, use of microphenomenology) to improve mind–brain mappings, but these are methodological proposals rather than implemented methods in this paper.
Results
Across multiple recent human neuroimaging studies synthesised in the review, increased measures of brain entropy under psychedelic compounds were consistently reported. Lempel-Ziv complexity (a compressibility-based measure of signal complexity) applied to MEG and EEG data showed higher complexity under LSD, psilocybin and ketamine, and these increases tended to correlate with subjective intensity of the psychedelic experience. fMRI studies also reported elevated spatial/temporal complexity under LSD and ayahuasca, with one report that acute increases in fMRI-measured entropy predicted changes in personality (increased openness) measured two weeks later. Separate work applying Lempel-Ziv measures to TMS-evoked EEG responses produced the perturbational-complexity index (PCI), which reliably differentiates disorders of consciousness (vegetative state, minimally conscious state, etc.), and spontaneous Lempel-Ziv measures have distinguished awake from anaesthetised states with high sensitivity. Beyond entropy per se, novel analyses such as connectome-harmonic decomposition revealed an expanded repertoire of brain states under LSD and evidence consistent with enhanced criticality, for example power-law distributions of connectome-harmonic activity. The review notes similar entropic increases with the NMDA antagonist ketamine and with DMT-containing ayahuasca, and highlights that not all external stimuli affect the psychedelic state equally—immersive, emotionally resonant inputs (for example, music matched to a patient) appear to have a stronger impact on subjective outcomes. The extracted text does not present pooled numerical effect sizes or confidence intervals; results are reported qualitatively and by study examples.
Discussion
Carhart-Harris interprets the aggregated findings as supporting the central claim that increased brain entropy indexes an expansion in the richness, complexity or information-content of conscious experience—up to an upper limit beyond which coherent phenomenal experience may fail. He frames this within a 'zone of criticality', proposing that normal waking consciousness sits toward the upper end of a sub-critical band, psychedelics shift dynamics closer to criticality or even toward super-criticality, and sedatives/anaesthetics shift dynamics downward. Heightened criticality is argued to confer maximal sensitivity to perturbation, which may explain why ‘set’ and ‘setting’ strongly shape psychedelic experiences and therapeutic outcomes. The review offers concrete proposals for advancing the theory empirically: combining dynamically sensitive brain measures (sliding windows, point-process, intrinsic ignition) with refined subjective sampling (experience sampling, microphenomenology); using structured stimuli such as music to time-lock likely epochs of insight; measuring the entropy of subjective reports (for example, linguistic richness); and applying machine-learning approaches while recognising that entropic states may be harder to predict. Carhart-Harris also links recent serotonin research to the hypothesis, noting evidence that dorsal raphe serotonin neurons signal 'surprise' or unsigned prediction error, which is formally related to uncertainty or entropy; 5-HT2A receptor signalling is suggested to relax prior beliefs and enhance plasticity, a mechanism consistent with increased entropy facilitating novel learning. Limitations acknowledged in the paper include its selective focus, the absence of systematic comparisons with stimulants (so that alternate explanations like general arousal cannot yet be fully ruled out), the need for more spatially localised analyses, and unresolved details about how entropy relates to criticality. The author concedes the speculative nature of parts of the update and reiterates that the entropic-brain framework is intended as a heuristic to guide testable hypotheses rather than a definitive account. The review also revises one earlier claim—the suggestion that seizures are sub-critical relative to waking activity—because evidence points to super-critical dynamics in seizures.
Conclusion
Four years after the original entropic brain proposal, Carhart-Harris maintains that the hypothesis has accrued empirical support and remains a useful, if speculative, heuristic. The paper concludes that entropy is a powerful bridge between measurable brain dynamics and subjective experience and that pursuing entropy- and criticality-focused research may advance understanding of consciousness and inform therapeutic approaches for psychiatric and neurological conditions.
Study Details
- Study Typemeta
- Populationhumans
- Journal
- Topics
- Author
- APA Citation
References (56)
Papers cited by this study that are also in Blossom
Alonso, J. N., Romero, S., Mañanas, M. A. et al. · International Journal of Neuropsychopharmacology (2015)
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Barrett, F. S., Preller, K. H., Herdener, M. et al. · Cerebral Cortex (2017)
Bedi, G., Cecchi, G. A., Slezak, D. F. et al. · Neuropsychopharmacology (2014)
Bogenschutz, M. P., Johnson, M. W. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)
Rodríguez-Fornells, A., Ribeiro, S., Sanches, R. F. et al. · European Neuropsychopharmacology (2015)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Show all 56 referencesShow fewer
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Carhart-Harris, R. L., Roseman, L., Bolstridge, M. et al. · Scientific Reports (2017)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Carrillo, F., Sigman, M., Fernández Slezak, D. et al. · Journal of Affective Disorders (2018)
Carter, O., Burr, D. C., Pettigrew, J. D. et al. · Journal of Cognitive Neuroscience (2006)
Frecska, E., Móré, C. E., Vargha, A. et al. · Journal of Psychoactive Drugs (2012)
Gallimore, A. R. · Frontiers in Human Neuroscience (2015)
Harman, W. W., McKim, R. H., Mogar, R. E. et al. · Psychological Reports (1966)
Hartogsohn, I. · Journal of Psychopharmacology (2016)
Kaelen, M., Roseman, L., Kahan, J. et al. · European Neuropsychopharmacology (2016)
Kaelen, M., Giribaldi, B., Raine, J. et al. · Psychopharmacology (2018)
Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)
Kraehenmann, R., Schmidt, A., Friston, K. et al. · NeuroImage (2015)
Sumiyoshi, T., Kraehenmann, R., Pokorny, D. et al. · Frontiers in Pharmacology (2017)
Kraehenmann, R. ;., Pokorny, D. ;., Vollenweider, L. ;. et al. · Psychopharmacology (2017)
Kuypers, K. P. C., Riba, &. J., De La Fuente Revenga, &. M. et al. · Psychopharmacology (2016)
Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)
Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)
Lebedev, A. V., Kaelen, M., L€ Ovd En, M. et al. · Human Brain Mapping (2016)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Millière, R. · Frontiers in Human Neuroscience (2017)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)
Lenz, C., Dolder, P. C., Lang, U. E. et al. · Acta Psychiatrica Scandinavica (2017)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Preller, K. H., Pokorny, D., Hock, A. et al. · PNAS (2016)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Roseman, L., Leech, R., Feilding, A. et al. · Frontiers in Human Neuroscience (2014)
Roseman, L., Sereno, M. I., Leech, R. et al. · Human Brain Mapping (2016)
Roseman, L., Demetriou, L., Wall, M. B. et al. · Neuropharmacology (2018)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Sampedro, F., de la Fuente Revenga, M., Valle, M. et al. · International Journal of Neuropsychopharmacology (2017)
Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Schenberg, E. E., Alexandre, J. F. M., Filev, R. et al. · PLOS ONE (2015)
Schmidt, A., Müller, F., Lenz, C. et al. · Psychological Medicine (2017)
Speth, J., Speth, C., Kaelen, M. et al. · Journal of Psychopharmacology (2016)
Sanz, C., Zamberlan, F., Erowid, E. et al. · Frontiers in Neuroscience (2018)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Timmermann, C., Spriggs, M. J., Kaelen, M. et al. · Neuropharmacology (2018)
Valle, M., Maqueda, A. E., Rabella, M. et al. · European Neuropsychopharmacology (2016)
Viol, A., Palhano-Fontes, F., Onias, H. et al. · Scientific Reports (2017)
Cited By (79)
Papers in Blossom that reference this study
McCulloch, D. E. W., Olsen, A. S., Ozenne, B. et al. · Nature Communications (2026)
Carhart-Harris, R. L. · Brain (2026)
Tabaac, B. J., Carhart-Harris, R. L., Yung, T. · Frontiers in Pharmacology (2026)
Subramani, V., Pascarella, A., Brunel, J. et al. · Biorxiv (2026)
Lyons, T., Spriggs, M. J., Kerkelä, L. et al. · Nature Communications (2026)
Lewis-Healey, E., Pallavicini, C., Cavanna, F. et al. · Journal of Cognitive Neuroscience (2025)
Irrmischer, M., Aqil, M., Luan, L. et al. · Journal of Neuroscience (2025)
Prochazkova, L., van Elk, M., Marschall, J. et al. · Neuropsychopharmacology (2025)
Vohryzek, J., Luppi, A. I., Atasoy, S. et al. · Neuropsychopharmacology (2025)
Tylš, F., Páleníček, T., Klučková, T. et al. · Pharmacological Reports (2025)
Show all 79 papersShow fewer
Roseby, W., Kettner, H., Roseman, L. et al. · Frontiers in Psychology (2025)
Singleton, S. P., Timmermann, C., Luppi, A. I. et al. · Communications Biology (2025)
Safron, A., Juliani, A., Reggente, N. et al. · Neuroscience of Consciousness (2025)
Brouwer, A., Brown, J., Erowid, E. et al. · npj Mental Health Research (2025)
Zeifman, R. J., Spriggs, M. J., Kettner, H. et al. · Scientific Reports (2025)
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Tipado, Z., Kuypers, K. P. C., Sorger, B. et al. · European Neuropsychopharmacology (2024)
Peill, J. M., Marguilho, M., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)
Berit, S., Meling, D., Hirsch-Hoffmann, M. et al. · Scientific Reports (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Mediano, P. A. M., Rosas, F. E., Timmermann, C. et al. · ACS Chemical Neuroscience (2024)
Rosas, F. E., Mediano, P. A. M., Timmermann, C. et al. · Biorxiv (2023)
Vohryzek, J., Cabral, J., Timmermann, C. et al. · National Science Review (2023)
McCulloch, D. E-W., Olsen, A. S., Ozenne, B. et al. · MedRvix (2023)
Weiss, B., Wingert, A., Erritzoe, D. et al. · Scientific Reports (2023)
Girn, M., Rosas, F. E., Daws, R. E. et al. · Trends in Cognitive Sciences (2023)
Herzog, R., Mediano, P. A. M., Rosas, F. E. et al. · Scientific Reports (2023)
Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Kaup, K. K., Vasser, M., Tulver, K. et al. · Frontiers in Psychiatry (2023)
Ruffini, G., Damiani, G., Lozano-Soldevilla, D. et al. · PLOS ONE (2023)
Luppi, A. I., Vohryzek, J., Kringelbach, M. L. et al. · Communications Biology (2023)
Aqil, M., Roseman, L. · Neuropharmacology (2022)
Bedford, P., Hauke, D. J., Wang, Z. et al. · Neuropsychopharmacology (2022)
Gattuso, J. J., Perkins, D., Ruffell, S. G. D. et al. · International Journal of Neuropsychopharmacology (2022)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Barba, T., Buehler, S., Kettner, H. et al. · BJPsych Open (2022)
Girn, M., Roseman, L., Bernhardt, B. et al. · NeuroImage (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
Li, D., Vlisides, P. E., Mashour, G. A. · NeuroImage (2022)
Tagliazucchi, E. · Frontiers in Pharmacology (2022)
Ciauncia, A., Safron, A. · Psyarxiv (2022)
Vollenweider, F. X., Smallridge, J. W. · Pharmacopsychiatry (2022)
Zamani, A., Carhart-Harris, R. L., Christoff, K. · Neuropsychopharmacology (2021)
Khan, S. I., Carter, G. T., Aggarwal, S. K. et al. · Frontiers in Neuroscience (2021)
Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)
Healy, C. J., Lee, K. A. · Chronic Stress (2021)
Savino, A., Nichols, C. D. · Biorxiv (2021)
Leptourgos, P., Bouttier, V., Denève, S. et al. · Psyarxiv (2021)
Yaden, D. B., Johnson, M. W., Griffiths, R. R. et al. · International Journal of Neuropsychopharmacology (2021)
Carhart-Harris, R. L., Wagner, A. C., Agrawal, M. et al. · Journal of Psychopharmacology (2021)
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A. et al. · NeuroImage (2021)
Zeifman, R. J., Singhal, N., Breslow, L. et al. · ACS Pharmacology and Translational Science (2021)
Thomas, C. W., Blanco-Duque, C., Breant, B. et al. · Translational Psychiatry (2021)
Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Sanz, C., Pallavicini, C., Carrillo, F. et al. · Consciousness and Cognition (2021)
Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Girn, M., Mills, C., Roseman, L. et al. · NeuroImage (2020)
Smith, W. R., Sisti, D. · Journal of Medical Ethics (2020)
Barnett, L., Muthukumaraswamy, S., Carhart-Harris, R. L. · NeuroImage (2020)
Agin-Liebes, G. I., Malone, T., Yalch, M. M. et al. · Journal of Psychopharmacology (2020)
Watts, R., Luoma, J. B. · Journal of Contextual Behavioral Science (2020)
Kettner, H., Gandy, S., Haijen, E. C. H. M. et al. · International Journal of Environmental Research and Public Health (2019)
Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)
Luoma, J. B., Sabucedo, P., Eriksson, J. et al. · Journal of Contextual Behavioral Science (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Scott, G., Carhart-Harris, R. L. · Neuroscience of Consciousness (2019)
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Bayne, T., Carter, O. · Neuroscience of Consciousness (2018)
Timmermann, C., Roseman, L., Williams, L. et al. · Frontiers in Psychology (2018)